treatments with fewer side effects than ordinary pain relievers, two randomized trials presented here with negative results should at least narrow your search. In one, colchicine proved to be no ...

In the cited meta-analysis, colchicine was associated with reduced risk of treatment failure (OR: 0.23) and recurrent pericarditis (OR: 0.39), but with a trend toward more adverse effects.